{"filing":{"accession_number":"0001213900-26-071793","cik":"0001584371","ticker":"ICCM","company_name":"IceCure Medical Ltd.","form":"6-K","filing_date":"2026-06-25","report_date":null,"primary_document":"ea0295921-6k_icecure.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1584371/000121390026071793/ea0295921-6k_icecure.htm"},"events":[{"id":13757,"run_id":12220,"accession_number":"0001213900-26-071793","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"IceCure announced on June 25, 2026, that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after the closing bid price reached $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company had previously fallen below the $1.00 minimum bid price threshold and faced potential delisting, but has now cured that deficiency. The announcement explicitly states \"Nasdaq considers the bid price deficiency matter now closed,\" confirming resolution of a material listing compliance issue.","company_name":"IceCure Medical Ltd.","ticker":"ICCM","filing_date":"2026-06-25","form":"6-K","submitted_at":null,"items":[{"id":10988,"accession_number":"0001213900-26-071793","item_number":"EX-99.1","item_title":"ea029592101ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"IceCure announced on June 25, 2026, that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after the closing bid price reached $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company had previously fallen below the $1.00 minimum bid price threshold and faced potential delisting, but has now cured that deficiency. The announcement explicitly states \"Nasdaq considers the bid price deficiency matter now closed,\" confirming resolution of a material listing compliance issue.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T12:46:37.802646+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10988,"accession_number":"0001213900-26-071793","item_number":"EX-99.1","item_title":"ea029592101ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"IceCure announced on June 25, 2026, that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after the closing bid price reached $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company had previously fallen below the $1.00 minimum bid price threshold and faced potential delisting, but has now cured that deficiency. The announcement explicitly states \"Nasdaq considers the bid price deficiency matter now closed,\" confirming resolution of a material listing compliance issue.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-25T12:46:37.802646+00:00","company_name":"IceCure Medical Ltd.","ticker":"ICCM","filing_date":"2026-06-25"}]}